Hunan Luying Technology key facts
as of Oct 2026- Developer and manufacturer of high-resolution Single Photon Emission Computed Tomography (SPECT) scanners and core components designed for molecular imaging diagnostics.
- Hunan Luying Technology is valued at approximately $15.6M as of Oct 2026 (last reported valuation).
- It has raised $4.3M; the latest was Seed Round ($4.3M) in Dec 2025.
- Notable investors include Guangzhou Jinkong Fund, Hunan Guochuang Industrial Investment, AVE Technology.
- Status: Privately Held (backing).
Hunan Luying Technology's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·Watch Hunan Luying Technology: the Monday email on marks, rounds and moves
Hunan Luying Technology funding rounds
No funding rounds for Hunan Luying Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Hunan Luying Technology
3Hunan Luying Technology valuation
Hunan Luying Technology's last reported valuation was $15.6 million in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
Hunan Luying Technology investors
3 investors are on record for Hunan Luying Technology, including Guangzhou Jinkong Fund, Hunan Guochuang Industrial Investment and AVE Technology.
About Hunan Luying Technology
Developer and manufacturer of high-resolution Single Photon Emission Computed Tomography (SPECT) scanners and core components designed for molecular imaging diagnostics. The company provides domestically produced SPECT and SPECT/Computed Tomography (SPECT/CT) systems and key modules, enabling healthcare providers with precise, safe, cost-effective, and accessible nuclear medicine imaging solutions.
- Sector
- Healthcare
- HQ
- Changsha, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.